Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep-Oct;19(5):264-7.

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia

Affiliations

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia

Jacques De Greef et al. Cardiovasc J Afr. 2008 Sep-Oct.

Abstract

Background: Amino terminal pro-B-type natriuretic peptide (NT-proBNP) is a sensitive marker of ventricular dysfunction. Exercise causes an increase in the secretion of NTproBNP, and with myocardial ischaemia the increase is more pronounced. This increase has been found to improve the diagnostic sensitivity of the stress ECG in diagnosing myocardial ischaemia in subjects with normal ventricular function.

Objective: To assess whether the change in NT-proBNP can be used to diagnose effort-induced myocardial ischaemia in an unselected population.

Methods: We enrolled a total of 51 consecutive patients, referred for exercise stress 99mTc-sestamibi SPECT MPI (single-photon emission computed tomography myocardial perfusion imaging) to diagnose inducible myocardial ischaemia. NT-proBNP was determined at rest and 30 minutes after cessation of exercise.

Results: Of the 51 patients, 28 had normal perfusion scans, seven had scans with fixed perfusion defects (previous myocardial infarction with no inducible ischaemia) and 16 had reversible perfusion defects (inducible ischaemia). There was no correlation between ischaemia and resting NT-proBNP, post-stress NT-proBNP or the change in NTproBNP (delta-NT-proBNP).

Conclusion: In an unselected population the change in NTproBNP cannot be used to diagnose effort-induced myocardial ischaemia.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Subject groups. 1 = no perfusion defect (28 patients); 2 = fixed perfusion defect, no ischaemia (7 patients); 3 = reversible defect, inducible ischaemia (16 patients).
Fig. 2.
Fig. 2.
The relationship between the degree of ischaemia (SDS) and delta-NT-proBNP (post-stress – resting NT-proBNP).
Fig. 3.
Fig. 3.
The relationship between NT-proBNP and EDV (end-diastolic volume).

Similar articles

Cited by

References

    1. Costello-Boerrigter LC, Burnett JC (jun). The prognostic value of N-terminal proB-type natriuretic peptide. Nat Clin Pract Cardiovasc. 2005;2:194–201. - PubMed
    1. Anand IS, Fisher LD, Chiang Y, Latini R, Masson S, Maggioni AP. et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsaratan Heart Failure Trial (Val-HeFT). Circulation. 2003;107:1278–1283. - PubMed
    1. Schnabel R, Lubos E, Rupprecht H, Espinola-Klein C, Bickel C, Lackner KJ. et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina. J Am Coll Cardiol. 2006;47:552–558. - PubMed
    1. Pegoraro NR, Naidoo DP, Esterhuizen TM. Prognostic value of Nterminal-pro-brain natriuretic peptide measurement in patients with acute coronary syndromes. Cardiovasc J S Afr. 2006;17:60–66. - PubMed
    1. Morrow DA, De Lemos JA, Blazing MA, Sabatine MC, Murphy SA, Jarolim P. et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. J Am Med Assoc. 2005;294:2866–2871. - PubMed